PPARG and cancer: Indeed, PPARγ agonists including anti-diabetic agents, polyunsaturated fatty acids as well as non-steroidal anti-inflammatory drugs (NSAID) [14,15] have been demonstrated to affect proliferation and differentiation in cancer cell lines [16].